Topologically engineered antibodies and Fc-fusion proteins: a new class of multifunctional therapeutic candidates for SARS-CoV-2, cancer, and other disease
Capon, D. J.; Troitskaya, L.; Chan, N. L. S.; Fomin, M.; Edman, U.; Frank, B.; Jin, J.; Martinelli, R.; Capon, B. Z.; Ferguson, G. A.; Gefter, M. L.; Simmons, G.
Show abstract
The ability of antibodies and Fc-fusion proteins to bind multiple targets cooperatively is limited by their topology. Here we describe our discovery that ACE2 Fc-fusion proteins spontaneously cross-dimerize, forming topologically distinct "superdimers" that demonstrate extraordinary SARS-CoV-2 intra-spike cooperative binding and potently neutralize Omicron B.1.1.529 at least 100-fold better than eight clinically authorized antibodies. We also exploited cross- dimerization to topologically engineer novel superdimeric antibodies and Fc-fusion proteins with antibody-like plasma half-lives to address cancer and infectious disease therapy. These include bispecific ACE2-antibody superdimers that potently neutralize all major SARS-CoV-2 variants, and bispecific anti-cancer and anti-viral antibody superdimers that are more potent than two-antibody cocktails. Superdimers are efficiently produced from single cells, providing a new therapeutic approach to many disease indications.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody 97%
- Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages 96%
- Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein 96%
Similar papers in this journal
- Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies 96%
- CYpHER: Catalytic extracellular targeted protein degradation with high potency and durable effect 95%
- Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.